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Abstract:
Purpose:
Aim  of  this  retrospective,  observational  study  is  to  describe  features  of  a  population  sample,  affected  by  primary  open  angle
glaucoma (POAG) in order to evaluate damage progression on the basis of the emerged individual risk factors.
Methods:
We included 190 caucasian patients (377 eyes), evaluating relationship between individual risk factors (explicative variables) and
MD (Mean Deviation) of standard automated perimetry. We also considered the dependent variable NFI (Neural Fiber Index) of
GDx scanning laser polarimetry. Progression has been evaluated through a statistic General Linear Model on four follow up steps
(mean follow up 79 months).
Results:
Factors reaching statistical significance, determining a worsening of the MD variable, are: age (P<0.0001), intraocular pressure (IOP)
at follow up (P < 0.0001), female gender (P<0.0001), hypertension (P< 0.0001) and familiarity (P = 0.0006).
Factors reaching statistical significance, determining a worsening of the NFI variable, are only IOP at follow up (P = 0.0159) and
depression (P = 0.0104).
Conclusion:
Results of this study confirm and enforce data coming from most recent studies: IOP remains the main risk factor for glaucoma
assess and progression; age and familiarity are great risk factors as underlined in the last decades; female sex can be an important risk
factors as emerged only in the last years; arterial hypertension should always be evaluated in timing of our clinic follow up.
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INTRODUCTION
Open  angle  glaucoma  is  a  progressive  neurodegeneration  of  retinal  ganglion  cells  (RCGs)  and  their  axons
characterized  by  a  specific  pattern  of  visual  field  and  optic  nerve  head  damage  [1  -  3].
Clinical trials confirmed the importance of intraocular pressure (IOP) in the development and progression of open-
angle glaucoma, even if evidence suggests the existence of ocular and systemic factors, in addition to IOP, that can be
responsible of this development and progression [4 - 6].
Aim of our retrospective,  observational study is that to describe features of a population sample,  under treatment at
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the Glaucoma Centre of the Ophthalmologic Clinic of Turin University, in order to value the damage progression on the
basis of the emerged individual risk factors.
MATERIALS AND METHODS
This study was performed with the ethical standards laid down in the 1964 Declaration of Helsinki and its later
amendments.
In this observational, retrospective study, we included 190 patients (377 eyes) re-examined in the last 18 months
(January 2013 – June 2014) under treatment at the Glaucoma Centre of the Eye Clinic of Turin University.
All patients were caucasian, resident in Italy, affected by primary open angle glaucoma (POAG), with repeatable
visual field loss and acquired glaucomatous damages to optic nerve head or nerve fiber layer.
The inclusion parameters in the study foresaw:
presence of regular follow up examinations at our centre with a minimum of two examinations a year for at least
three subsequent years;
presence of at least one yearly visual field test (i.e. at least four assessable perimetrical tests), carried out with
the  30-2  or  24-2  SITA (Swedish  Interactive  Threshold  Algoritm)  standard  program of  the  Humphrey  Field
Analyzer (Carl Zeiss Meditec, Dublin, California, USA);
if present at least three assessable GDx-VCC scanning laser polarimetry (GDx nerve fiber analyzer, Carl Zeiss
Meditec Inc., Dublin, CA, USA) examination during the follow up period, with at least one year time distance
from each other.
Patients  were  classified  as  having  POAG  when  they  had  a  typical  glaucomatous  visual  field  and/or  a  typical
abnormal optic nerve head, open angle at gonioscopy, IOP > 21 mmHg with no treatment and no clinically apparent
secondary cause for their glaucoma [2].
A glaucomatous visual field defect was defined as:
three adjacent points depressed by 5 dB, with one of the points depressed by at least 10 dB or
two adjacent points depressed by 10 dB or
10 dB difference across the nasal horizontal meridian in two adjacent points.
None  of  the  points  could  be  edge  points  unless  immediately  above  or  below  the  nasal  horizontal  meridian.  In
addition, visual field testing was considered reliable only when false-negative and false-positive responses were less
than 30% and fixation losses were less than 20% on HFA. The abnormal optic nerve head classification was based on
the presence of an optic rim notch or of diffuse / generalized loss of optic rim tissue, vertical cup/disc diameter ratio
asymmetry unexplained by side differences in optic disc size, disc haemorrhage.
GDx data in the considered follow up period were disposable only for 56 patients (112 eyes). We decided to use the
NFI (Neural Fiber Index).
The exclusion parameters in the study foresaw:
lack of data and of an appropriate follow up;
unsatisfactory IOP compensation during the follow-up such that patients needed surgical intervention or valve or
stent implant;
onset of other ocular pathologies during the follow up period;
macular dystrophy or maculopathy diagnosis in patients with GDx data;
patients less than 18 years old;
pregnant or nursing women;
inability to understand and/or complete the tests.
The patients with an evolving cataract, such to create in itself a worsening of the visual acuity higher than 3/10 in
the whole follow up period, have been excluded.
In  order  to  analyse  the  sample,  we  used  an  anamnestic  questionnaire  created  on  purpose  for  our  study,  whose
compilation was carried out in presence of paramedical staff.
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For the recording of both epidemiological and clinical data we used the program “Glaucoma Management System
Database” (© Daniela Paoli, Italia) [7, 8].
This data processing program consists of a database of simple comprehension and offers the possibility to memorize
patients data as support for diagnosis and therapy; created to collect the whole patient case history, it allows the access
of recent and remote data in real time.
Concerning data extraction it  was necessary the use of  an additional  Access and Excel  (Microsoft  Corporation,
Redmond, WA, USA) programming developed by us.
Glaucomatous progression was defined of the basis of the dependent variable MD (Mean Defect) of the visual field
by means of the Generalized Linear Model (GLM) method. We already decided to analyze the dependent variable NFI
(Neural Fiber Index) of GDx [9].
The following explicative variables have been taken into consideration: age; gender, male or female; IOP at follow
up; pachymetry; myopia>4 dioptres; hypothyroidism; diabetes mellitus; hypercholesterolemia; arterial hypertension;
use of systemic and/or topical corticosteroids; hypoacusia; haemicrania; vasospasm; ischemic heart disease; smoke;
asthma; depression.
We measured IOP in mmHg with Goldmann applanation tonometer; we measured pachymetry as central corneal
thickness (CCT) with ultrasound pachymeter. About corticosteroids use we considered an extended time period therapy
(more than 15 days in the last 3 months before the follow up considered time).
In statistics, GLM is a flexible generalization of ordinary least squares regression [10, 11]. The term GLM indicates
a  whole  series  of  techniques  for  the  statistical  analysis  of  data  with  the  aim  of  predicting  the  behavior  of  certain
elements while other variables are changing. The aim is to model a phenomenon so as to obtain a law that has general
validity and can give indications on the phenomenon itself and be easily used. The general linear model incorporates a
number of different statistical models: ANOVA, ANCOVA, MANOVA, MANCOVA, ordinary linear regression, t test
and F test. The GLM generalizes linear regression by allowing the linear model to be related to the response variable via
a link function and by allowing the magnitude of the variance of each measurement to be a function of its predicted
value. GLMs were formulated by John Nelder and Robert Wedderburn as a way of unifying various other statistical
models, including linear regression, logistic regression and Poisson regression. They proposed an iteratively reweighted
least squares method for maximum likelihood estimation of the model parameters. Analysis was performed using SAS
9.1 program [12]. The effect of various individual characteristic on MD value at different observation times (t0 t1, t2,
t3) has been estimated using a general linear model for repetaed measures. The term “repeated measures” as used in this
paper  refers  to  multiple  responses  taken  in  sequence  on  the  same experimental  unit  ,e.g.,  a  patient.  The  feature  of
repeated  measures  experiments  that  requires  special  attention  in  data  analysis  is  the  correlation  pattern  among  the
responses on the same patient over time, as every tipical example of a factorial analysis.The model used is MD= age,
gender, IOP , pachymetry, , myopia>4 dioptres , hypothyroidism, diabetes mellitus, hypercholesterolemia , arterial
hypertension, corticosteroids, hypoacusia, haemicrania, vasospasm, ischemic heart disease, smoke, asthma, depression
where MD is  the dependent  variable and age,  gender,  IOP…are explicative variables.  We already decided to run a
model NFI=age, gender: male or female, IOP , pachymetry, , myopia>4 dioptres , hypothyroidism, diabetes mellitus,
hypercholesterolemia  ,  arterial  hypertension,  corticosteroids,  hypoacusia,  haemicrania,  vasospasm,  ischemic  heart
disease, smoke, asthma, depression for the 56 patients who had GDx data during all the follow up period. The effect of
the explicative variables has been initially tested in statistical univariate analysis; then, only the variables which have
shown a significant effect to the univariate analysis have been inserted in the final GLM model.
RESULTS
190 Caucasian patients (377 eyes) suffering from POAG, 76 males (40%) and 114 females (60%) were included.
The average age was equal to 61.49 ± 9.58 years (33.5-87.9). The average age among males was 60.1 ± 8.7 years
and the average age among females was 62.11 ± 10.1 years.
The average follow up in our study was of 79 months, equal to 6.58 years.
The question is which are the determinants, chosen among the most significant ones in literature, responsible of the
damage progression in patients suffering from POAG.
In the examined sample, factors that reach statistical significance, determining a worsening of the MD variable, are:
132   The Open Ophthalmology Journal, 2016, Volume 10 Actis et al.
age  (P<0.0001),  IOP  at  follow  up  (P  <  0.0001),  female  gender  (P<0.0001),  hypertension  (P<  0.0001)  and
familiarity  (p  =  0.0006)  (Table  1).
Table 1. Result of GLM model with MD variable. [From SAS 9.1 program].
Origin DF Sum of squares Mean square F value Pr>F
Model 110 0937.89105 372.16265 10.04 <.0001
Error 1091 40435.66245 37.06294    
Total not corrected 1201 81373.55350      
R-squared Coefficient of variation MSE root MD mean
0.265808 -130.0996 6.087934 -4.679442
Origin DF SS Type I Mean square F value Pr>F
Interc 1 26298.51157 26298.51157 709.56 <.0001
time 79 6492.16035 81.38178 2.20 <.0001
age cl 5 2250.54433 450.10887 12.14 <.0001
iop 21 2727.45848 129.87898 3.50 <.0001
sex 1 1501.48649 1501.48649 40.51 <.0001
hypertension 1 1154.476446 1154.476446 31.15 <.0001
familiarity 1 473.89027 473.89207 12.79 <.0004
depression 1 102.36332 102.36332 2.76 <.0968
Origin DF SS Type II Mean square F value Pr>F
Interc 1 4432.165511 4432.165511 119.58 <.0001
time 79 5636.033618 71.342198 1.92 <.0001
age cl 5 1965.695749 393.139150 10.61 <.0001
iop 21 2069.241142 99.821007 2.69 <.0001
sex 1 1827.737675 1827.737675 49.31 <.0001
hypertension 1 1300.542418 1300.542418 35.09 <.0001
familiarity 1 438.982088 438.982088 11.84 <.0004
depression 1 102.363315 102.363315 2.76 <.0968
In the examinated sample, factors that reach statistical significance, determining a worsening of the NFI variable,
are only IOP at follow up (P = 0.0159) and depression (P = 0.0104) (Table 2).
The other parameters taken into consideration do not reach statistical significance.
We also estimated that, on average, for each mmHg increase in IOP, there is a worsening of MD variable of -8.82
dB, equivalent to -1.34 dB per year (Table 3). This datum has been adjusted also for the fact that these are repeated
measures over time and for individual characteristics of the patient, so it can really estimate the real effect of the single
IOP on the parameter MD in time.
Table 2. Result of GLM model with NFI variable. [From SAS 9.1 program].
Origin DF Sum of squares Mean square F value Pr>F
Model 57 201694.6569 3538.5028 12.32 <.0001
Error 241 69235.3431 287.2836    
Total not corrected 298 270930.0000      
R-squared Coefficient of variation MSE root NFI mean
0.269959 69.72576 16.94944 24.30872
Origin DF SS Type I Mean square F value Pr>F
Interc 1 176092.4027 176092.4027 612.96 <.0001
time 35 12842.1444 366.9184 1.28 0.1476
age cl 5 2621.0812 524.2162 1.82 0.1086
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Origin DF SS Type I Mean square F value Pr>F
iop 13 7772.1127 597.8548 2.08 0.0159
sex 1 361.3364 361.3364 1.26 0.2632
familiarity 1 88.8787 88.8787 0.31 0.5786
depression 1 1916.7008 1916.7008 6.67 0.0104
Origin DF SS Type II Mean square F value Pr>F
Interc 1 25136.38400 25136.38400 87.50 <.0001
time 35 11574.48773 330.69965 1.15 0.2670
age cl 5 1952.12440 390.42488 1.36 0.2405
iop 13 5939.52624 456.88663 1.59 0.0384
sex 1 113.59970 113.59970 0.40 0.5301
familiarity 1 187.23025 187.23025 0.65 0.4203
depression 1 1916.70083 1916.70083 6.67 0.0104
Table 3. IOP effect calculation.
IOP* LSMEAN of MD C.I. 95%
  -8.820031 -13.722347 -6.035749
*Effects for one unit of IOP in mmHg
DISCUSSION
The  aetiology  of  POAG is  still  uncertain  up  to  today:  hence  the  importance  to  carry  out  new  epidemiological
studies.
In  literature  several  factors  have been indicated as  possible  risk  factors  [13].  If  we consider  studies  with  a  real
statistical significance a very few risk factors emerge indeed. The Canadian Glaucoma Study [4] stated that factors
leading to a worsening of the MD variable over time are age, female gender, high level of anticardiolipin antibodies and
IOP. Subsequent evaluations of the same group particularly emphasized the importance of the age and anticardiolipin
antibodies levels [6]. In a recent review Weinreb and Medeiros [14] summarized how the parameters with significance
are few: older age, family history of glaucoma, black race, use of systemic or topical corticosteroids, high intraocular
pressure.
From literature it is clear that the main risk factor is represented by IOP, already from year 1622 when Richard
Banister [15] gave the first accurate description of glaucoma in English language.
The statistical analysis we carried out has indicated that the main risk factor for the onset and the progression of the
damage is IOP: in particular each average increasing mmHg in the IOP means an average worsening of the MD variable
of -8.82 dB, equal to -1.34 dB a year.
The Early Manifest Glaucoma Trial, EMGT [16] study showed that each increasing mmHg of the IOP creates a
possible  growth  of  10%  in  the  progression  risk.  A  reduction  of  the  IOP  of  25%  obtained  through  a  standardized
treatment (laser + betaxolol) allowed a slowdown in the disease progression from 62% to 45% after 6 years of follow
up. In the end the study indicated the high IOP and the pseudoesfoliatio as the significant risk factors of the progression.
The  Canadian  Glaucoma  Study  [4]  confirmed  how  the  average  IOP  at  follow  up  (before  demonstrating  a
progression) was directly proportional to the progression itself.  Each mmHg increase of IOP caused a risk increase
approximately of 19%: this progression seemed more pronounced in the vasospastic patients.
Pressure peaks and IOP fluctuations play a decisive role: the Advanced Glaucoma Intervention Study (AGIS) [17]
showed  the  importance  of  the  IOP  variability  between  an  examination  and  the  other  as  risk  factor  of  the  damage
progression.
Our study indicates  also that,  once given the diagnosis  of  POAG, to  the age progression  corresponds a  higher
damage progression.
Considering prevalence, the glaucoma risk increasing with the age was noticed in almost all population studies.
Some Authors underlined as the real prevalence increase becomes significant after the age of 60 (studies of Ferndale
[18], Bedford [19], Dalby [20], Blue Mountains [21], Casteldaccia [22]) or even of 70 (Framingham [23], Baltimora
(Table 2) contd.....
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[24], Ponza [25]).
Chaunan [4] identified age as the main predictive independent factor: in this study the subjects older than 60 years
presented  an  incidence  of  glaucomatous  perimetrical  defects  seven  times  higher  than  the  one  surveyed  among  the
individuals under 40 years.
Coleman  and  Miglior  [26]  recently  proposed  a  review  dividing  the  patients  in  three  groups:  progression  from
normal subject to glaucomatous one; progression from subject suffering from ocular hypertension to glaucomatous one;
progression of the damage in the suffering subject. In all groups the age resulted to be a statistically significant risk
factor.
The same fact comes out from other studies [4, 27, 28]
Concerning gender, if we observe a sample of studies we can deduce that in some of them there is no statistically
significant difference, in other studies males seems to be more struck and in other studies the female gender [29].
The Canadian Glaucoma Study [4, 6] surveyed a risk factor in the female sex (HR 1.94 i.c. 1.09-3.46, p value .02),
but it surveyed an even higher risk factor in the presence of anti-cardiolipin antibodies (ACA) at high levels (HR 3.86
i.c. 1.60-9.31, p value .003).
Our study confirms how female gender can be associated to an higher damage progression. We can suppose that
also hormonal changes typical of females and related to the age itself could be responsible for these data [30, 31].
We also have to remember that cardiovascular risk can be higher in females.
The familiarity nature of glaucoma has been recognized from decades. In some studies, among those the Baltimore
Survey,  50% of  the  suffering patients  had a  positive  familiarity,  suggesting the  genetic  defect  as  important  for  the
pathology development [32].
The study carried out in Holland by Wolfs in 1998 surveyed a risk for relatives of first degree of a subject suffering
from POAG of 22% to develop the pathology, against a 2.3% of the general population checked [33].
Other studies indicate different increase degrees of the risk to develop POAG for the relatives of first degree which
go from 3 to 9 times in comparison with those of the normal population [34, 35].
Arterial hypertension and ocular hypertension seem to be correlated in several studies. The correlation between
arterial hypertension and glaucoma is less clear. Some studies confirm it, others don’t confirm this association [36].
The Los Angeles Latino Eye Study [37] recently demonstrated how the relation between glaucoma prevalence and
diastolic arterial pressure can be represented through a “U”-chart: the patients on both extremities of the spectrum result
to have an increased risk to develop this pathology. This apparent paradox can be explained with two considerations:
the first one is that patients are characterized by a low perfusion pressure at the level of the optic nerve head; the second
one is that chronic hypertension associated to atherosclerosis determines an increase of the vessels resistance and a
compromising of the vascular self-regulation, finally reducing nutritive exchanges at the level of the capillary bed of the
optic nerve head.
Leske [38] underlined how different clinical studies had demonstrated a strong correlation between low perfusion
pressure  and  damage  progression:  also  in  this  case  a  common  factor  could  be  the  alteration  of  the  vascular  self-
regulation.
According to the Blue Mountains Study [21], a low perfusion pressure rises the damage progression speed; also
sudden pressure drops during the night, lowering the perfusion pressure, are a risk factor for the damage progression.
The review of Werne of 2008 [39] concluded that the non physiologic PAOS drops during night and in general
sudden changes of the perfusion pressure are important risk factors correlated to the development and to the glaucoma
progression, even if there is no unanimous agreement in literature.
Joe et al. [40] included instead in their study 54 eyes of 54 patients with diagnosis of Normal Tension Glaucoma,
monitoring the PAOS during the night while they were sleeping in their usual position. The patients were so classified
in three groups: “non-dippers”, “dippers”, “over-dippers” according to the decrease degree of the night arterial pressure
compared  with  the  diurnal  one.  The  authors  created  regression  models  to  adjust  the  data  according  to  age,  central
corneal thickness (pachimetry), IOP value before the study, pressure parameters. In order to evaluate the onset and the
progression  of  the  damage,  they  used  the  MD  and  PSD  indexes  of  the  Humphrey  visual  field  ,  the  TSNIT  score
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(temporal,  superior,  nasal,  inferior,  temporal)  and  the  NFI  of  the  GDx-VCC.  This  study  demonstrated  as  a  nightly
reduction of the arterial pressure was directly linked to a damage progression.
Gugleta [41] underlined the importance of the vascular risk factors and of the oxidative stress, concluding that a
deep scan of the vascular risk profile has to be carried out in each glaucomatous patient.
Coming back to the present study a lot of supposed risk factors are not reaching statistical significance. They can
always play a role, even if considered alone are not the protagonists. For example ischemic heart attack or diabetes can
be linked to hypertension or vessel modifications.
Among the non significant factors in our study it is particularly interesting the role of central corneal thickness.
On  the  basis  of  the  results  of  the  OHTS  a  lot  of  importance  was  given  to  this  parameter,  proposing  universal
tonometric conversion algorithms; actually the weight of this risk factor is still to understand and studies with many
samples  are  necessary  to  come to  definitive  conclusions.  In  particular  it  is  necessary  to  analyse  three  aspects:  real
weight  of  the  pachymetry  on  the  intraocular  pressure;  link  between  pachymetry  and  other  factors  (is  it  only  a
mechanical  factor  in  the  applanation  with  the  Goldmann  tonometer?);  link  between  the  hypotonic  therapy  and  the
pachymetry [42 - 44]
We have at disposal several studies aimed to confirm or not an association between hypothyroidism and POAG:
these  studies  have  often  produced  conflicting  results  [45  -  48]  It  is  already  clear  the  relationship  between
hyperthyroidism,  particularly  in  Graves-Basedow  disease,  and  IOP  [49].
Some studies on population have investigated the possible association between POAG and hypothyroidism, starting
with the Blue Mountain Eye Study, [21] which includes 324 patients (8.9% of the considered population) with thyroid
problems of whom 147 (4% of the considered population) under thyroxin therapy. The POAG prevalence among the
patients with thyroid problems was of 4.6% against 2.8% of the resting population. Adjusting the data for confounding
factors, the result didn’t seem to be statistically significant even if there is an increased risk to develop POAG among
patients under levothyroxin therapy in comparison with the patients who didn’t reveal previous thyroid pathologies.
These results, as underlined by Cross [49], are not completely clear. The recent paper by Haefliger states there we
don’t’ have enough evidence to state a relationship between hypothiroidism and glaucoma [50].
Considering the GDx GLM we decided to construct, IOP remains the only real risk factor reaching significance.
Depression datum can be interesting, but it has got some limitations also because it should be re-evaluated for each
patient. We believe that during the anamnestic questionnaire under the label “depression” patients should have included
different pathologies. For sure we can state that:
glaucoma seems related to depression, anxiety and sleep disorders in several studies; [51 - 53]
it is not clear the role of systemic therapies for these pathologies on IOP;
there is a strong evidence that glaucoma is linked to neurological pathologies, such as Alzheimer disease, that
can have also a pathogenetic relationship with depression in elderly [54 - 56].
POAG has important similarities with other neurodegenerative diseases: it has been shown that RCGs and the optic
nerve  mechanisms  of  cell  death  are  similar  to  those  of  Alzheimer's  disease.  In  particular  deposits  of  β-amyloid,
characteristic of Alzheimer's disease, have recently been implicated in the pathogenesis of glaucoma. Amyloid β42 is
not soluble and can deposit and lead to apoptosis. Evidence suggests that patients suffering from Alzheimer's disease
have a higher incidence and prevalence of glaucoma, as well as patients suffering from glaucoma are characterized by a
higher incidence and prevalence Alzheimer's disease.Some studies have also shown that Alzheimer's disease leads to
abnormalities in the retina: reduction of the nerve fiber layer (RNLF), venous constriction and decreased blood flow in
these veins [57].
Concluding this discussion we would like to underline the relationship between structure (optic nerve and fibers)
and function (visual field). First of all we have to state that is much more difficult to talk about progression only with a
structural model. This because the relationship between structure and function is not always clear nor immediate [58].
It 's true that usually a thinning of the RNFL precedes somehow a functional damage, but it’s not a general rule.
In some patients we can observe a worsening of the structural parameters without then having functional (and so
clinical decision) changes. In other patients we can see functional changes without major structural changes [59 - 62].
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The American Academy of  Ophthalmology recently underlined how no OCT (actually the main device used to
analyze structure) on US market has got a stand-alone indication for diagnosis of glaucoma [63].
Certainly, it is interesting that IOP remains the only parameter that has a strong significance related to a structural
deterioration evaluated with the GDx and with his index NFI on a follow-up of 6.58 years. In clinical practice it is good
to rely on multiple tools that assess the structure (HRT, GDx and particularly OCT) in order to have a clear idea of
whether or not a progression of the damage.
Our study has got several limitations:
we should enlarge the population sample, i.e. with a multicentrical study;
we should improve structural analysis, particularly with a large population sample and an evaluation with OCT;
we  should  improve  data  coming  from  the  anamnestic  questionnaire,  re-evalutaing  some  pathologies  (i.e.
depression);
we should factor into our analyses time to progression (dividing “fast  progressors” and “slow progressors”)
considering differences between the two groups;
we should also consider the hypotonizing therapy for each patient, but we have to state that our center follows
EGS Guidelines in order to reach for each patients the IOP target and a good tonometric compense.
CONCLUSION
Results of this study confirm and enforce data coming from most recent studies:
IOP remains the main risk factor for glaucoma assess and progression;
age and familiarity are great risk factors as underlined in the last decades;
female sex can be an important risk factors as emerged only in the last years: this is an important confirmation
of the last literature results;
arterial hypertension can be an important risk factor as widely explained in the present discussion.
This  study  can  underline  how  in  glaucomatous  patients  a  careful  clinical  history  with  an  internal  medicine
perspective is now compulsory and a general medical evaluation of the patient is undoubtedly useful: only in this way it
is possible to develop a personalized follow up with an appropriate timing.
Glaucoma is  still  today a  mistery  but,  exactly  for  this,  stimulating for  the  scientific  research:  only  in  a  clinical
research  context  we  could  disclose  it  in  the  future  defeating  in  this  way  the  first  cause  of  irreversible  blindness
worldwide.
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